SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $95,037 | -22.4% | 136,059 | 0.0% | 0.02% | -26.7% |
| Q4 2022 | $122,453 | -96.2% | 136,059 | -74.6% | 0.03% | -95.3% |
| Q3 2022 | $3,215,000 | +18.9% | 536,059 | -18.0% | 0.64% | +29.8% |
| Q2 2022 | $2,704,000 | +8.9% | 653,448 | 0.0% | 0.49% | +51.2% |
| Q1 2022 | $2,482,000 | -12.3% | 653,448 | +3.8% | 0.33% | -22.7% |
| Q4 2021 | $2,831,000 | -3.5% | 629,384 | 0.0% | 0.42% | +103.9% |
| Q3 2021 | $2,934,000 | -35.4% | 629,384 | -2.3% | 0.21% | -43.6% |
| Q2 2021 | $4,540,000 | +13.6% | 644,056 | -4.8% | 0.37% | +171.9% |
| Q1 2021 | $3,997,000 | -57.7% | 676,294 | +105.7% | 0.14% | -82.1% |
| Q2 2020 | $9,457,000 | – | 328,824 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 870,820 | $13,071,000 | 14.74% |
| RA Capital Management | 4,681,858 | $70,275,000 | 4.19% |
| Cormorant Asset Management, LP | 858,382 | $12,884,000 | 0.78% |
| Monashee Investment Management LLC | 62,500 | $938,000 | 0.43% |
| TPG Group Holdings (SBS) Advisors, Inc. | 3,771,878 | $56,616,000 | 0.42% |
| DC Investments Management, LLC | 35,502 | $533,000 | 0.31% |
| Eventide Asset Management | 425,000 | $6,379,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 610,000 | $9,156,000 | 0.02% |
| Weiss Asset Management LP | 14,150 | $212,000 | 0.02% |
| Zimmer Partners, LP | 100,000 | $1,501,000 | 0.02% |